Ocular Implants Market Size Worth $18.4 Billion By 2025

The global ocular implants market size is expected to reach USD 18.4 billion by 2025, growing at a CAGR of 6.7%, according to a new report by Grand View Research, Inc. The increase in the incidence of cataracts is a major factor driving the growth of the market. Cataract has been identified as a leading cause of blindness globally, and this has encouraged many industry players and government organizations to develop ocular implants.

Technological advancements and increasing acceptance of vision correction coupled with the fast adoption of intraocular lenses in cataract surgeries are the factors supporting this market’s growth. For instance, a new collagen glaucoma implant that inhibits the formation of scar and is biodegradable has been developed.

Eye research institutes play a vital role in the technological advancements associated with intraocular lenses. The advent of various advanced intraocular lenses and an increase in competition amongst players for the development of better lenses as well as a rise in investment in eye research institutes by government and non-government organizations are anticipated to fuel market growth. Hence, owing to the rise in the number of clinical trials pertaining to these lenses and an increase in government expenditure on R&D, the market is expected to witness lucrative growth in the intraocular segment.

In addition, an increase in ophthalmic disorders and demand for better eye implants are creating abundant growth opportunities for this market, which is expected to increase the number of players in the market.

Click the link below:

Further key findings from the report suggest:

  • Intraocular lenses, corneal implants, orbital implants, glaucoma implants, and ocular prosthesis are the key segments analyzed in this study. The glaucoma implants segment was identified as the largest and is expected to grow at a CAGR of over 6.0% during the forecast period.
  • North America is one of the most lucrative regions for ocular implants due to the growing aging population and the easy availability of reimbursement facilities, which boosts the regional market.  The U.S. is the most dominating country in this region, owing to a large population having supportive insurance coverage, technological advancements, and an aging population, which is more prone to cataracts.
  • Ophthalmic clinics in developing countries are working toward providing affordable eye care services, which in turn encourages medical tourism in these countries. As a result, the demand for intraocular lenses is increasing in developing countries, thereby, driving ocular implants market growth.
  • Some key players are Bausch & Lomb Incorporation; Alcon Inc.; Johnson & Johnson Vision Care; Carl Zeiss Meditec AG.; MORCHER GmbH; and STAAR Surgical

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s